Immune Therapy for Pancreatic and Colon Cancer expands the knowledge on pathways, immune modulators, immune check points, and monoclonal antibodies that can lead to appropriate cancer treatment. With a strong focus on the development of immune therapies to improve the survival rates of pancreatic and colon cancer, this book also shows the latest trends in immune targeted approaches for cancer treatment. Sections describe the role of and the immune response to pancreatic and colon cancer, gives insights to past and current immunotherapies, including metabolic reprogramming, immune blockade therapy and immune modulation.
This book is a valuable resource for health professionals, scientists and researchers, students, and all those who wish to broaden their knowledge of the advances in immunotherapy in pancreatic and colon cancer, inspire them and guide their design of novel experimental projects and translational studies.
This book is a valuable resource for health professionals, scientists and researchers, students, and all those who wish to broaden their knowledge of the advances in immunotherapy in pancreatic and colon cancer, inspire them and guide their design of novel experimental projects and translational studies.
Table of Contents
1. Immune response to pancreatic and colon cancer2. Role of Monoclonal antibodies in cure of pancreatic and colon cancer
3. Vaccine-based immunotherapy for pancreatic and colon cancer.
4. New targets in the immunotherapy for pancreatic and colon cancer
5. Molecular mechanisms of immune-oncology therapies for pancreatic and colon cancer
6. Metabolic reprogramming in pancreatic and colon cancer
7. Oncolytic virus-immunotherapy in pancreatic and colon cancer
8. Role of PD 1 as immunotherapeutic target
9. Immune blockade therapy for pancreatic and colon cancer
10. Role of circulating tumor cells in immunotherapy of pancreatic and colon cancer
11. Role of T-cells in immunotherapy of pancreatic and colon cancer
12. Immune modulation for pancreatic and colon cancer immunotherapy
13. Immune check points of pancreatic and colon cancer and its utilization in immunotherapy